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Abstract
Background: A new rectal cooling device for therapeutic hypothermia (TH) therapy is designed and is applied in
TH treatment of SD rats with ischemic-hypoxic brain damage.
Methods: Healthy adult SD rats (n = 45) were randomly assigned into four groups: the healthy control group (n = 5),
the ischemia and hypoxia group (n = 10), the rectal TH cooling group (n = 18), and the ice blanket TH cooling group
(n = 11). The rats in the rectal cooling and ice blanket TH groups received 12 h treatment after hypoxic-ischemic brain
damage had been established, while those in the ischemia and hypoxia group did not. Taking the start of TH as the
zero point, rats were sacrificed after 24 h and the brain and rectum tissues were sampled for histological analysis.
Results: The TH induction time (37.3 ± 14.7 min) in the rectal cooling group was significantly shorter (F = 4.937,
P < 0.05) than that in the ice blanket cooling group (75.6 ± 27.2 min). The HE and NISSL staining results showed
that rats in the rectal TH cooling group had significantly decreased (P < 0.01) positive neurons cell count
compared to those in ischemia and hypoxia group. In addition, TUNEL staining indicated that the number of
apoptotic cells (3.9 ± 1.8 cells / × 400 field) and the apoptosis index (4.4 % ± 1.5) were significantly lower in
rectal TH cooling group (P < 0.05) than in ischemia and hypoxia group (23.2 ± 12.1 cells / × 400 field, 26.6 % ± 12.1).
Also, no rectal frostbite or inflammatory infiltration was observed in rats in the rectal TH treatment groups.
Conclusion: Our new cooling device realized rapid TH induction in SD rats with ischemic-hypoxic brain damage,
inhibited the apoptosis of cells in the hippocampal CAl region, and did not cause histological damage to the rectal
tissues.
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Background
Therapeutic hypothermia (TH) therapy plays a signifi-
cant role in the functional protection of brain, heart,
liver, kidney, and other vital organs in patients undergo-
ing cardiopulmonary resuscitation or suffering from
hypoxic-ischemic brain damage and multiple organ
failures [1–5]. When neonatal suffering from hypoxic-
ischemic brain damage,which also called neonatal
hypoxic-ischemic encephalopathy, many neonatal center
have established hypothermia as the only effective
treatment available [6–8]. In those patients TH therapy
could improve cellular energy metabolism; decrease
basal metabolic rate of tissues and organs, consumption
of oxygen and energy, generation of oxygen radicals and
intracellular calcium overload; improve cell necrosis and
apoptosis; promote the recovery of intercellular signal-
ing; alleviate cerebral edema and reduce intracranial
pressure. TH therapy could significantly improve
patient’s quality of life and lessen the rate of disability or
mortality. The earlier the therapy is given, the more
significant the protective effect will be.
Therapeutic hypothermia (TH) is defined as a core
body temperature of 28–35 °C. The temperature con-
trolled within 32–34 °C is often considered safe and,
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therefore, is most commonly used for the TH therapy on
experiment animals. This is because, within this range,
the blood pressure, blood oxygen, carbon dioxide partial
pressure, blood pH and blood glucose would not be
influenced, and no pathological damages would occur in
animals’ heart, lung, kidney, small intestine and other
organs.
Nowadays, a variety of methods could be used for TH
cooling, and the cooling devices have also undergone
continuous improvement and development. Reported
methods for TH cooling include ice bag cooling, ice
blanket cooling, intravenous infusion of a low-temperature
liquid, extracorporeal blood cooling, intravascular catheter
cooling, blood filtration, and selective head cooling [9–15].
Some TH therapy devices introduced by top hospitals are
too expensive for hospitals in small counties or villages to
afford, and too large to move, thus limiting their application
in prehospital TH treatment. These shortcomings signifi-
cantly inhibit the promotion of TH therapy, and may even
delay the treatment opportunity for critically sick patients.
With the increasingly wide applications of TH therapy,
how to develop a fast and economical cooling device has
become one research hot spot. In this study, a new rectal
cooling device for therapeutic hypothermia (TH) therapy
was designed and used to treat SD rats with ischemic-
hypoxic brain damage, which serves as an experimental
basis for future clinical trials.
Methods
Experimental animals
Healthy SD rats (male and female), weighing 250–300 g
were provided by the Laboratory Animal Center of
Chongqing Medical University.
The design of a new rectal TH cooling device (Fig. 1)
The inserted inflow and outflow tubes have different
lengths. The end of the inflow tube is inserted into the
bottom of the hydration bladder, and the end of the out-
flow tube is inserted to a depth approximately at the
anal entrance. Low-temperature liquid flows into the hy-
dration bladder via the inflow tube and flows out via the
outflow tube. The hydration bladder is closed at the
bottom and functions only for liquid storage. The length
of the bladder is equivalent to that of the rectum (5 cm).
In this study, 0 °C ice-water mixture was used as a
low-temperature infusion circulation liquid. A infant
transfusion needle without the needle handle was used
as the inflow and outflow tubes. A balloon was used as
the hydration bladder. The speed controller and con-
nector used for circulation were also used in this device.
The guiding wire provided with the urethral catheterization
pack was used for inserting the hydration bladder. 500-mL
or 1000-mL infusion bag was used as the liquid storage
bag. Two temperature probes were respectively connected
to the inflow and outflow tubes for detecting the
temperature of the water at two ends, thereby evaluating
the heat exchange effect and preventing excessively low
temperature.
Animal grouping
Healthy adult SD rats (n = 51) were randomly assigned
into four groups: the healthy control group (n = 5), the
ischemia and hypoxia group (n = 10), the rectal TH
cooling group (n = 18), and the ice blanket (HICO-VAR-
IOTHERM550,German) TH cooling group (n = 11). The
rats in the ischemia and hypoxia group, rectal TH
cooling group and ice blanket TH cooling group had in-
duced hypoxic-ischemic brain damage. The rats in the
rectal cooling and ice blanket TH groups were treated
with therapeutic hypothermia later, but those in the
ischemia and hypoxia group received no treatment. The
rats in the healthy control group were normal healthy
rats without any form of treatment.
Anesthesia
Wang et al. [16] suggested that studies concerning cere-
bral temperature variation or therapeutic hypothermia
should choose anesthetic methods and agents having less
influence on brain temperature. Our pilot study showed
that intraperitoneal anesthesia had a greater influence
on experiment animals; thus rectal administration of
chloral hydrate was used in this study. Before TH treat-
ment, SD rats were weighed and anesthetized via rectal
infusion of 10 % chloral hydrate (0.3 mL/kg). During TH
treatment, animals were sedated with 10 % chloral
hydrate (0.1 mL/kg) every 2 h.
Establishment of an ischemia and hypoxia model
The hypoxic-ischemic brain damage model was con-
structed based on the method reported by Rice et al.
[17]. After anesthetizing rats with 10 % chloral hydrate,
the left common carotid artery was isolated and ligated.
Then, rats were returned to recover for 2 h in their
cages. Subsequently, they were placed into a hypoxia
box with an air flow of 8 % O2 and 92 % N2 mixture at a
rate of 2 L/min for 2 h. Rats showing left-side rotation




Rats in the rectal TH cooling group were anesthetized and
connected to the rectal cooling device with the infusion
rate at 160 dtt/min. Rats in the ice blanket TH cooling
group were anesthetized and placed on the blanket
(HICO-VARIOTHERM 550,Germany). The temperature
of the blanket was set at 15 °C. Rats’ tympanic temperature
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was measured every 15 min and the time needed to reach
TH (35 °C) was also recorded.
Maintenance of TH
After TH induction, rats’ tympanic temperature was
maintained at 33–35 °C for 12 h by adjusting the speed
of water inflow or the temperature of the blanket. From
the start of TH induction to the first 6 h of TH mainten-
ance, rats’ tympanic temperature was measured every
30 min and during the next 6 h of TH maintenance, the
temperature was measured every 1 h. Far Infrared
treatment was given if the tympanic temperature fell to
the lower limit (33 °C), but the circulation of ice-water
and TH treatment were maintained.
Temperature recovery
After TH treatment, rats were returned to their cages
for steady temperature recovery. The room temperature
was maintained within 25–26 °C. During the recovery
time, the tympanic temperature of rats should also be
monitored to ensure the increasing rate of temperature
was lower than 0.5 °C/h and the total time for recovery
Fig. 1 Schematic diagram of the rectal TH cooling device 1: The inflow tube; 2: the outflow tube; 3: The hydration bladder; 4: The speed
controller; 5: The connector: Connectors could be linked to common infusion sets, and different connectors could be designed according to
study needs; 6: The guiding wire: The guiding wire is used to insert the hydration bladder into the rectum of rats; 7: The removable liquid bag:
The bag functions for liquid storage and is connected to both the inflow and outflow tubes. An insulation bag was designed for the bag
connected to the inflow tube. Different insulation bags could be designed according to study needs
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was ≥ 5 h. This approach could protect rats from
rebound hypercalcemia and hypovolemic shock induced
by rapid temperature recovery.
Taking the beginning of TH as the zero point, the rats
were sacrificed and their brain sampled after 24 h. The
rectal tissue was taken for HE staining to identify frost-
bite and inflammatory infiltration.
Determination of cell apoptosis
Since TUNEL staining could not distinguish necrotic
and apoptotic cells, this study used three different stain-
ing methods (TUNEL, HE, and NISSL staining) to deter-
mine the causes of cell death. Cells that tested positive
to TUNEL staining, presented with round or oval-
shaped dark purple-colored chromatin (≥2) and intact
nuclear membrane after HE and NISSL staining were
considered as apoptotic cells. On the other hand, cells
that displayed eosinophilic cytoplasm or nuclear rupture,
and dispersed chromatin were considered as necrotic
cells. Normal cells should show negative TUNEL stain-
ing, uniform HE/NISSL staining, and intact nuclear
membrane.
Under a high-power microscope, 10 high-power fields
(×400) in the hippocampal CAl region were selected to
count neuronal cells positively or negatively stained by
different reagents. The apoptosis index (AI) was calcu-
lated by AI = TUNEL-positive cell count / (TUNEL-posi-
tive cell count + TUNEL-negative cell count) × 100 %.
Statistical analysis
Data is presented as means ± SD. The software SPSS
17.0 was used for statistical analysis. Inter-group com-
parison was made by ANOVA. P < 0.05 was defined as
statistical significance.
Results
The efficiency of TH induction
During TH induction, the time needed to reach TH (35 °C)
in the rectal cooling group was 37.3 ± 14.7 min, which was
significantly shorter (F = 4.937, P < 0.05) than that in the
variable temperature blanket cooling group (75.6 ±
27.2 min) (Fig. 2). During TH maintenance, the tympanic
temperature of rats in both groups was maintained within
33–35 °C. Thanks to careful monitoring, no rats were sacri-
ficed for temperature recovery-induced side effects.
HE staining of rectal mucosa
24 h after rectal cooling, no frostbite or inflammatory
infiltration was observed (Figs. 3 and 4).
HE staining in the hippocampal CAl region
Rats in the ischemia and hypoxia group displayed sig-
nificant cell damage with decreased pyramidal cell
count, reduced cell size, nuclear pyknosis and cell
disorder. However, rats in the rectal TH treatment
group showed significantly increased number of
pyramidal cells (Table 1).
NISSL staining in the hippocampal CAl region
Rats in the ischemia and hypoxia group had significantly
decreased number of pyramidal cells in the CAl region,
while rats in the rectal TH cooling group had increased
pyramidal cells, but the level was still lower than that of
the healthy control group (Table 2).
TUNEL staining in the hippocampal CAl region
The number of apoptotic neurons and the AI were deter-
mined and calculated using TUNEL staining. As for the
ischemia and hypoxia group, a lot of cells in hippocampal
CAl tested positive to TUNEL staining, while cells in the
rectal TH cooling group showed fewer positive neurons
after TUNEL staining (Table 3).
Discussion
It has been reported that the incidence of neonatal
hypoxic-ischemic encephalopathy has reached 1.5/1000
[17, 18]. Several multi-center randomized controlled trials
were carried out to evaluate the effects of TH induction
(33.5–34.5 °C) in neonates (born at > 36 weeks’ gestational
age) with moderate or severe hypoxic-ischemic encephal-
opathy, the results showed that TH treatment significantly
decreased the mortality of newborns. Also, these studies
found a lower incidence of neurodevelopmental disability
in the TH-treated group; therefore, researchers have pro-
posed treatment of hypoxic-ischemic encephalopathy with
TH induction [6, 7, 18–28].
Though many cooling methods have been developed,
their disadvantages still exist. The ice blanket is slow in
decreasing the core body temperature, so its cooling effi-
ciency cannot meet the requirement of diseases that
need rapid TH induction. Besides, the ice blanket ma-
chine is too expensive for leading hospitals to afford,
and the low mobility limits its application in pre-
hospital emergency situations. Another cooling method,
intravenous infusion of a low-temperature liquid, has
shown high cooling efficiency when applied in clinical
practice. It seems as an attractive strategy to achieve
early cooling because of its portability, ease in adminis-
tration, and potential widespread availability in the pre-
hospital setting [12]. However, the indications, infusion
liquid temperature, and the influence on vital signs,
immune systems, hemodynamics and coagulation func-
tions require verification; Though intravascular catheter
cooling, extracorporeal blood cooling, and blood filtra-
tion can all achieve rapid TH induction, the requirement
for vascular access placement may delay the treat-
ment time and thereby affect the outcome of TH
therapy [29–31]. What’s more, no studies have yet
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been published in which these devices have been used
for longer-term (>24 h) cooling. Moreover, the above
cooling methods have a great impact on the blood
system, and, as a result, should be closely monitored
by professional clinicians; which also hinders the
promotion and application of TH therapy. The select-
ive cerebral hypothermia method exerts a relatively
small influence on systemic functions; consequently, it
is more commonly used in cerebral resuscitation and
brain protection for patients with emergent or severe
neurosurgery injury [32]. However, this cooling strat-
egy also requires further investigation regarding the
direct monitoring of brain temperature, the selection
of infusion vessels, the in vitro cooling circuit as well
as the choice of infusion liquids.
The theoretical basis of this study is that ice-cold
isotonic saline enema is a safe cooling method in fever
patients, based on this, we proposed an optimal design
for a disposable rectal TH cooling device. Two flow
tubes are inserted into a closed storage bladder (elon-
gated balloon) to realize a continuous cooling with iso-
tonic ice-cold saline and animal’s core temperature is
controlled by adjusting the rate of saline flow. This de-
sign achieved a satisfactory cooling efficiency; there was
Fig. 2 The efficiency of TH induction for the rectal cooling group and the variable temperature blanket cooling group (see more detail in
Additional file 1)
Fig. 3 Rectal longitudinal section of healthy control HE × 400
Fig. 4 Rectal longitudinal section of rats that underwent rectal
cooling HE × 400
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no direct contact between the saline and rectal mucosa,
therefore, adverse reactions such as water intoxication
could be well prevented.
Animal experiments showed that our rectal cooling
device has achieved a higher efficiency of TH induction
(37.3 ± 14.7 min) compared to the variable temperature
blanket (75.6 ± 27.2 min). We also found that the
temperature rise in the ice-blanket group at 330 mins. It
may associated with shivering and heat generation. Fur-
thermore, it also showed a favorable effect on SD rat
protection and did not cause damage to the rectum of
rats. Based on the Program of Hypothermia Treatment
of Neonatal Hypoxic-Ischemic Encephalopathy (2001)
[33], this study established a specific protocol for TH
treatment using rectal cooling. This method could act as
the basis for clinical application and promote the wide
use of TH treatment.
There are some potential limitations of the current
trial. First, the effect of brain protection in patients
undergoing therapeutic hypothermia (TH) using ice-
water circulating blanket has beeen confirmed by re-
searchers, so we have no comparison between rectal TH
and blanket TH rats using HE,NISSL and TUNEL
staining.
Second, due to limited experimental conditions, we
did not evaluate the vital signs of rats nor the long-term
influence of TH treatment on rats’ neural system. Thus,
the influence of this TH cooling device on rats’ vital
signs and long-term recovery of neural functions are un-
known. These potential limitations should be considered
in the context of the trial’s strengths.
Conclusion
1. Both the variable temperature blanket and our
device achieved TH induction in rats with hypoxic-
ischemic brain damage, but our device showed a
higher cooling efficiency compared to the blanket.
2. Our rectal TH cooling device did not cause damage
to rats’ rectal tissues.
3. TH treatment with our new device significantly
decreased cell apoptosis in rats’ hippocampal CAl.
4. Our new cooling device is easy to carry and so
might be applied in pre-hospital treatment and im-
prove patients’ prognosis.
Additional file
Additional file 1: Detail about rectal temperature in Rectal and Blanket
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Table 2 Positive neurons of NISSL staining in hippocampus CA1
(mean ± SD)
Group Number Positive neurons cell count in
hippocampus CA1 (cells/× 400 field)
Healthy control 5 0.00 ± 0.00
Ischemia and hypoxia
group
10 20.08 ± 5.40
Rectal TH cooling group 18 4.90 ± 2.20
P1 < 0.01 compared with the healthy control; P2 < 0.01 compared with the
ischemia and hypoxia group
Table 3 TUNEL positive cells and apoptosis index in
hippocampus CA1 (mean ± SD, %)
Group Number Positive cell count
(cells / × 400 field)
AI (%)
Healthy control 5 0 0
Ischemia and hypoxia group 10 23.2±7.7 26.6±12.1
Rectal TH cooling group 18 3.9±1.8 4.4±1.5
P1 < 0.05 compared with the healthy control; P2 < 0.05 compared with the
ischemia and hypoxia group
Table 1 Positive neuron of HE staining in hippocampus CA1
(mean ± SD)
Group Number Positive neurons cell count in
hippocampus CAl (cells/× 400 field)
Healthy control 5 0.00 ± 0.00
Ischemia and hypoxia
group
10 32.48 ± 7.56
Rectal TH cooling group 18 6.30 ± 3.46
P1 < 0.01 compared with the healthy control; P2 < 0.01 compared with the
ischemia and hypoxia group
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